Cantargia (Sweden) Today
| CANTA Stock | SEK 1.77 0.10 5.35% |
Performance0 of 100
| Odds Of DistressLess than 46
|
Cantargia is selling for under 1.77 as of the 18th of January 2025; that is 5.35 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.74. Cantargia has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 166.99 M outstanding shares. More on Cantargia AB
Moving together with Cantargia Stock
Moving against Cantargia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cantargia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cantargia's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cantargia or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chief Executive Officer | Goran Forsberg |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Cantargia AB (CANTA) is traded on Stockholm Exchange in Sweden and employs 27 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 915.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cantargia's market, we take the total number of its shares issued and multiply it by Cantargia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cantargia AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 166.99 M outstanding shares.
Cantargia AB has accumulated about 842.44 M in cash with (346.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cantargia Probability Of Bankruptcy
Ownership AllocationCantargia holds a total of 166.99 Million outstanding shares. 30% of Cantargia AB outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cantargia Ownership Details
Cantargia AB Risk Profiles
Although Cantargia's alpha and beta are two of the key measurements used to evaluate Cantargia's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.26 | |||
| Standard Deviation | 4.86 | |||
| Variance | 23.58 | |||
| Risk Adjusted Performance | (0.13) |
Cantargia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cantargia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Cantargia Corporate Directors
| Karin Leandersson | Director | Profile | |
| Anders MartinLof | Director | Profile | |
| Thoas Fioretos | Director | Profile | |
| Patricia Delaite | Director | Profile |
Additional Tools for Cantargia Stock Analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.